iRhythm Technologies (NASDAQ: IRTC) — Perfil da empresa, notícias e dados financeiros
iRhythm Technologies innovates in cardiac monitoring, enhancing patient outcomes through digital health solutions.
iRhythm Technologies
iRhythm Technologies (NASDAQ:IRTC) specializes in healthcare solutions, focusing on the advancement and proliferation of cardiac monitoring technologies. It is solely listed on the NASDAQ stock market under the ticker symbol IRTC. The company is keenly centered around innovating in the field of digital health, striving to enhance patient outcomes and streamline cardiac care through its state-of-the-art monitoring devices and data analysis tools. iRhythm aims to transform the way cardiac arrhythmias are clinically diagnosed by making its technology accessible and easy to use for both healthcare providers and patients. Through its dedicated research and development efforts, iRhythm aspires to lead in the discovery of new methods and solutions that promote heart health and well-being globally.
Resumo
Operações
Produtos e/ou serviços de iRhythm Technologies
- Zio XT is a wearable cardiac monitor that allows for long-term continuous heart rhythm monitoring, providing detailed reports for diagnosis.
- Zio AT is an auto-trigger looping monitor capturing abnormal heart rhythms, offered for shorter monitoring periods.
- Zio Service includes the proprietary algorithms and expert analysis by certified technologists, offering in-depth insights into the collected data.
- myZio is a patient-centric app designed to improve the patient experience by facilitating better communication and engagement during the monitoring period.
- Zio Watch, a smartwatch-based solution, offers continuous ECG monitoring aimed at detecting atrial fibrillation and other heart rhythm irregularities.
- Research and Development focused on advancing cardiac monitoring technology, aiming to enhance accuracy, patient compliance, and overall diagnostic yield.
equipe executiva do iRhythm Technologies
- Quentin S. BlackfordPresident, CEO & Director
- Daniel G. WilsonCFO & Principal Financial Officer
- Minang P. TurakhiaChief Medical & Scientific Officer and Executive VP of Advanced Technologies
- Patrick Michael MurphyChief Business & Legal Officer
- Chad M. PattersonChief Commercial and Product Officer
- Mervin SmithExecutive Vice President of Business Operations
- Marc RosenbaumSenior VP of Finance & Chief Accounting Officer
- Brian LawrenceExecutive VP & CTO
- Lisa PecoraSenior Vice President of Finance & Investor Relations
- Sean Clinton FreemanExecutive Vice President of Strategy & Corporate Development
Principais indicadores financeiros
Resultados divulgados pela iRhythm Technologies, em USD.
- Cap. de mercado
- 4,1 bi
- Receita (TTM)
- 825,3 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.4
- Dividend yield
- —
- Margem de lucro
- -1.7%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 747,1 mi | -36,8 mi | -44,6 mi | |
| 591,8 mi | -115,5 mi | -113,3 mi | |
| 492,7 mi | -125,2 mi | -123,4 mi | |
| 410,9 mi | -113,8 mi | -116,2 mi |